Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
7 Stocks to Buy for the Rest of 2023
06:10am, Tuesday, 29'th Aug 2023
The NASDAQ index, which lost one-third of its value last year, has rebounded with vigor in the first half of 2023. It climbed a staggering 32% during the period, channeling the spirit of 1983 when the
Late-Summer Steals: 7 Stocks to Buy Before Fall
09:48pm, Monday, 28'th Aug 2023
With summer coming to an end, investors may want to target certain compelling stocks to buy now. Basically, the theory is the reverse of the adage, sell in May and go away.
3 Surprisingly Underrated Stocks to Buy Right Now
06:55am, Saturday, 26'th Aug 2023
Investors aren't giving AbbVie nearly enough credit for its post-Humira strategy. CRISPR Therapeutics' pipeline offers stronger prospects than its stock performance indicates.
2 Stocks With Growth Potential
02:20pm, Friday, 25'th Aug 2023
In the fast-paced arena of stock trading, a glittering prize awaits those with the acumen to spot it: affordable growth stocks.
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
10:31am, Friday, 25'th Aug 2023
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
12:01pm, Thursday, 24'th Aug 2023
AbbVie's (ABBV) newer products, Skyrizi and Rinvoq, are performing extremely well and have the potential to make up for lost Humira revenues.
AbbVie: Still A Buy According To Buffett's 10xEBT Rule
04:06pm, Wednesday, 23'rd Aug 2023
AbbVie investors have good reason to be concerned about the company's future return potential. Sales are expected to fall markedly this year due to the patent expiration of Humira in domestic markets.
7 Very Oversold High-Yield Stocks to Buy Right Now
03:16pm, Wednesday, 23'rd Aug 2023
If you have the temptation to speculate, but are hesitant to go full bore into the madness of memes, oversold high-yield stocks to buy offer plenty of punch. Specifically, I'm focusing on well-establi
7 Top Dividend Stocks for Income and Stability
09:03pm, Monday, 21'st Aug 2023
When it comes to investing in dividend stocks, some investors focus mainly on yield. This can sometimes lead to investing too heavily in stocks that, while offering a high yield, could end up becoming
These 3 Large-Cap Pharma Stocks Have Been Red-Hot
09:02pm, Monday, 21'st Aug 2023
Large-cap pharmaceuticals have enjoyed buying pressure over the last month, delivering outsized gains to investors. And these three stocks have helped lead the charge.
Trillion-Dollar Trio: These 3 Super Growth Stocks Will Dominate the Market by 2035
08:31pm, Thursday, 17'th Aug 2023
A trillion-dollar valuation by a single company was once unthinkable even just a few years ago. After all, the S&P 500 was created in 1957 when the total market capitalization of the index was $172 bi
AbbVie (ABBV) Gets EU Approval for Migraine Prevention Drug
01:17pm, Thursday, 17'th Aug 2023
Following the approval, AbbVie's (ABBV) Aquipta is the first and the only oral CGRP receptor antagonist approved in the EU to prevent episodic and chronic migraines.
1 High-Yield Dividend Stock That Looks Like a Screaming Buy
08:45am, Thursday, 17'th Aug 2023
AbbVie is managing its much-anticipated loss of U.S. patent exclusivity for Humira as well as could be expected. The rest of the company's business is strong, and it looks in no danger of decreasing o
3 Dividend Aristocrats Positively Surprising Investors
06:27pm, Tuesday, 15'th Aug 2023
The bulk of the Q2 season is in the rearview mirror, but the quarterly results from these 3 Dividend Aristocrats shouldn't be ignored.
7 Blue-Chip Stocks Smart Investors Should Be Loading Up on Now
04:25pm, Monday, 14'th Aug 2023
There's a reasonable argument to be made that investors should load up on blue-chip stocks regularly. After all, large and well-established firms with long track records of success are likely to conti
